secwatch.observer — SEC 8-K summary
======================================

Issuer:     Medtronic plc (MDT)
CIK:        0001613103
Form:       8-K
Filed at:   2024-05-23T23:59:59+00:00
Accession:  0001613103-24-000058
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medtronic reports Q4 FY24 revenue $8.59B, organic growth 5.4%; FY25 EPS guidance $5.40-$5.50
--------------------------------------------------------------------------------

- Q4 GAAP diluted EPS $0.49, non-GAAP $1.46; FY24 GAAP diluted EPS $2.76, non-GAAP $5.20.
- FY24 revenue $32.4B (+3.6% reported, +5.2% organic); Q4 revenue $8.59B (+0.5% reported, +5.4% organic).
- FY25 guidance: organic revenue growth 4%-5%; non-GAAP EPS $5.40-$5.50 (4-6% growth).
- Dividend increased to $0.70 quarterly ($2.80 annual), 47th consecutive year of dividend increase.
- Broad-based organic growth: Neuroscience +6.5%, Cardiovascular +4.0%, Medical Surgical +4.5%, Diabetes +11.1% in Q4.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1613103/000161310324000058/0001613103-24-000058-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1613103/000161310324000058/mdt-20240523.htm
  HTML page:      https://secwatch.observer/filing/0001613103-24-000058

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer